{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:27Z","timestamp":1790645067747,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Chronic morphine treatment leads to decreased survival in control mice, but not in sickle mice. Chronic morphine treatment leads to hyperalgesia in sickle mice, but does not lead to analgesic tolerance.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018024299","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T20:55:52Z","timestamp":1552942552000},"page":"869-873","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease"],"prefix":"10.1182","volume":"3","author":[{"given":"Huy","family":"Tran","sequence":"first","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sagi","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waogwende","family":"Leonce Song-Naba","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mittal","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Lamarre","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biostatistical Design and Analysis Center, Clinical and Translational Sciences Institute, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"issue":"23","key":"2020021109190744500_B1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"2020021109190744500_B2","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"issue":"20","key":"2020021109190744500_B3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"2020021109190744500_B4","doi-asserted-by":"crossref","first-page":"540154","DOI":"10.1155\/2015\/540154","article-title":"Morphine for the treatment of pain in sickle cell disease","volume":"2015","author":"Gupta","year":"2015","journal-title":"Sci World J"},{"issue":"19","key":"2020021109190744500_B5","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J Clin Oncol"},{"issue":"23","key":"2020021109190744500_B6","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"key":"2020021109190744500_B7","doi-asserted-by":"crossref","first-page":"i109","DOI":"10.1093\/bja\/aeu351","article-title":"Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer","volume":"113","author":"Zylla","year":"2014","journal-title":"Br J Anaesth"},{"key":"2020021109190744500_B8","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br J Anaesth"},{"issue":"2","key":"2020021109190744500_B9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cct.2011.11.018","article-title":"Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial","volume":"33","author":"Peters-Lawrence","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"2020021109190744500_B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.23341","article-title":"Patients with sickle cell disease have increased sensitivity to cold and heat","volume":"88","author":"Brandow","year":"2013","journal-title":"Am J Hematol"},{"issue":"5","key":"2020021109190744500_B11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"issue":"12","key":"2020021109190744500_B12","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2020021109190744500_B13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2020021109190744500_B14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.V126.23.986.986","article-title":"Characteristics and potential biomarkers for chronic pain in patients with sickle cell disease [abstract]","volume":"126","author":"Kuei","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2020021109190744500_B15","doi-asserted-by":"crossref","first-page":"e0160608","DOI":"10.1371\/journal.pone.0160608","article-title":"Comparative analysis of pain behaviours in humanized mouse models of sickle cell anemia","volume":"11","author":"Lei","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"2020021109190744500_B16","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V92.9.3148","article-title":"Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis","volume":"92","author":"Michaels","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2020021109190744500_B17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcmd.2015.12.006","article-title":"Quantification of pain in sickle mice using facial expressions and body measurements","volume":"57","author":"Mittal","year":"2016","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"2020021109190744500_B18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: a systematic review of the literature","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2020021109190744500_B19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/17474086.2016.1126177","article-title":"Common gynecological challenges in adolescents with sickle cell disease","volume":"9","author":"Stimpson","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"5339","key":"2020021109190744500_B20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"P\u00e1szty","year":"1997","journal-title":"Science"},{"key":"2020021109190744500_B21","article-title":"Diet and gender influence survival of transgenic Berkley sickle cell mice [published online ahead of print 14 February 2019]","author":"Jahagirdar","journal-title":"Haematologica"},{"issue":"1","key":"2020021109190744500_B22","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1002\/cpns.54","article-title":"Mouse models of pain in sickle cell disease","volume":"85","author":"Sagi","year":"2018","journal-title":"Curr Protoc Neurosci"},{"key":"2020021109190744500_B23","author":"National Heart, Lung, and Blood Institute"},{"issue":"5","key":"2020021109190744500_B24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"issue":"10","key":"2020021109190744500_B25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","article-title":"Survival in adults with sickle cell disease in a high-income setting","volume":"128","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"18","key":"2020021109190744500_B26","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020021109190744500_B27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpain.2017.08.010","article-title":"Daily opioid use fluctuates as a function of pain, catastrophizing, and affect in patients with sickle cell disease: an electronic daily diary analysis","volume":"19","author":"Finan","year":"2018","journal-title":"J Pain"},{"issue":"3","key":"2020021109190744500_B28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(95)70472-8","article-title":"Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease","volume":"126","author":"Dampier","year":"1995","journal-title":"J Pediatr"},{"issue":"3","key":"2020021109190744500_B29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.21027","article-title":"Pharmacogenetics of morphine: potential implications in sickle cell disease","volume":"83","author":"Darbari","year":"2008","journal-title":"Am J Hematol"},{"issue":"1","key":"2020021109190744500_B30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/dmd.32.1.98","article-title":"Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice","volume":"32","author":"Nagar","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"2020021109190744500_B31","unstructured":"Food and Drug Administration. Guidance for industry: S1C(R2) dose selection for carcinogenicity studies. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm074919.pdf. Accessed 15 July 2018."},{"issue":"2","key":"2020021109190744500_B32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpain.2012.10.016","article-title":"Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges","volume":"14","author":"Bruehl","year":"2013","journal-title":"J Pain"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/6\/869\/1554720\/advances024299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/6\/869\/1554720\/advances024299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:53:31Z","timestamp":1581432811000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/6\/869\/246714\/Effect-of-chronic-opioid-therapy-on-pain-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018024299","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]}}}